Preparing for cell culture scale-out: establishing parity of bioreactor- and flask-expanded mesenchymal stromal cell cultures

Manufacturing Differences Affect Human Bone Marrow Stromal Cell Characteristics and Function: Comparison of Production Methods and Products from Multiple Centers

(2017) Shutong Liu et al.   Scientific Reports

Large-scale progenitor cell expansion for multiple donors in a monitored hollow fibre bioreactor

(2016) Toon Lambrechts et al.   CYTOTHERAPY

Mesenchymal Stromal Cell Secretion of Programmed Death-1 Ligands Regulates T Cell Mediated Immunosuppression

(2016) Lindsay C. Davies et al.   STEM CELLS

Stem Cell Therapies in Clinical Trials: Progress and Challenges

(2015) Alan Trounson et al.   Cell Stem Cell

The translation of cell-based therapies: clinical landscape and manufacturing challenges

(2015) Thomas RJ Heathman et al.   Regenerative Medicine

Bringing regenerative medicines to the clinic: the future for regulation and reimbursement

(2015) Tania Bubela et al.   Regenerative Medicine

Market Access of Atmps: Overview and Expected Challenges

(2015) E Hanna et al.   VALUE IN HEALTH

Bioprocessing strategies for the large-scale production of human mesenchymal stem cells: a review

(2015) Krishna M. Panchalingam et al.   Stem Cell Research & Therapy

Concise Review: Process Development Considerations for Cell Therapy

(2015) Andrew Campbell et al.   Stem Cells Translational Medicine

Immunoregulation by Mesenchymal Stem Cells: Biological Aspects and Clinical Applications

(2015) Marta E. Castro-Manrreza et al.   Journal of Immunology Research

A xenogeneic-free bioreactor system for the clinical-scale expansion of human mesenchymal stem/stromal cells

(2014) Francisco dos Santos et al.   BIOTECHNOLOGY AND BIOENGINEERING

Efficient manufacturing of therapeutic mesenchymal stromal cells with the use of the Quantum Cell Expansion System

(2014) Patrick J. Hanley et al.   CYTOTHERAPY

Manufacturing models permitting roll out/scale out of clinically led autologous cell therapies: regulatory and scientific challenges for comparability

(2014) Paul Hourd et al.   CYTOTHERAPY

IDO-Independent Suppression of T Cell Effector Function by IFN- -Licensed Human Mesenchymal Stromal Cells

(2014) R. Chinnadurai et al.   JOURNAL OF IMMUNOLOGY

Long Term Expansion of Bone Marrow-Derived hMSCs on Novel Synthetic Microcarriers in Xeno-Free, Defined Conditions

(2014) Martial Hervy et al.   PLoS One

Cell-based therapy approaches: the hope for incurable diseases

(2014) Ella Buzhor et al.   Regenerative Medicine

Production of mesenchymal stromal/stem cells according to good manufacturing practices: a review

(2013) Luc Sensebé et al.   Stem Cell Research & Therapy

Indoleamine 2,3 dioxygenase and metabolic control of immune responses

(2012) David H. Munn et al.   TRENDS IN IMMUNOLOGY

The MSC: An Injury Drugstore

(2011) Arnold I. Caplan et al.   Cell Stem Cell

Mesenchymal stromal cell ‘licensing’: a multistep process

(2011) M Krampera   LEUKEMIA

Human MSC Suppression Correlates With Cytokine Induction of Indoleamine 2,3-Dioxygenase and Bystander M2 Macrophage Differentiation

(2011) Moïra François et al.   MOLECULAR THERAPY

Multipotent Mesenchymal Stromal Stem Cell Expansion by Plating Whole Bone Marrow at a Low Cellular Density: A More Advantageous Method for Clinical Use

(2011) Katia Mareschi et al.   Stem Cells International

Maximizing the ex vivo expansion of human mesenchymal stem cells using a microcarrier-based stirred culture system

(2010) Gemma Eibes et al.   JOURNAL OF BIOTECHNOLOGY

Expansion of mesenchymal stem cells using a microcarrier-based cultivation system: growth and metabolism

(2008) D. Schop et al.   Journal of Tissue Engineering and Regenerative Medicine

Effects of fluid flow and calcium phosphate coating on human bone marrow stromal cells cultured in a defined 2D model system

(2007) S. Scaglione et al.   JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A